Related Experiment Video
Updated: Jun 30, 2025

10:50
Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice
Published on: November 3, 2013
24.6K
Skeletal muscle atrophy after sciatic nerve damage: Mechanistic insights
1Clinical Biochemistry Laboratory, Department of Biochemistry, Maharshi Dayanand University, Rohtak, 124001, Haryana, India.
European Journal of Pharmacology
|March 16, 2024
Summary
Sciatic nerve injury causes muscle atrophy by altering intracellular calcium levels, impacting signaling pathways and mitochondrial function. This review explores molecular regulators of denervation-induced muscle loss for potential therapeutic targets.
Area of Science:
- Muscle physiology and molecular biology
- Neuroscience and regenerative medicine
- Biochemistry and cellular signaling
Background:
- Sciatic nerve injury triggers molecular changes leading to muscle dysfunction and atrophy.
- Nerve damage causes sustained muscle relaxation, elevating intracellular calcium (Ca2+) levels.
- Elevated Ca2+ impacts key cellular signaling pathways (AMPK, Akt/mTOR) and mitochondrial function.
Purpose of the Study:
- To review and evaluate molecular regulators of denervation-induced muscle atrophy following sciatic nerve damage.
- To understand the interplay between synthesis and inhibitory stimuli in muscle mass regulation.
- To identify potential pharmacological targets for treating muscle loss.
Main Methods:
- Literature review of existing research on denervation-induced muscle atrophy.
- Analysis of molecular events, signaling pathways, and mitochondrial dysfunction.
- Evaluation of differential gene and protein expression regulators.
Main Results:
- Sciatic nerve injury leads to increased mitochondrial Ca2+ sensitivity, mitophagy, and atrophy.
- Activated AMP-activated protein kinase (AMPK) negatively regulates the Akt/mTOR pathway, crucial for anabolism.
- Controversial outcomes exist regarding signaling pathway behavior in denervation-induced muscle loss.
Conclusions:
- Understanding signaling pathway interactions is key to addressing muscle mass loss after sciatic nerve damage.
- Identifying regulators of muscle atrophy can inform novel pharmacological interventions.
- Further research is needed to resolve conflicting data on denervation-induced muscle loss mechanisms.

